Anti-snoring Devices And Snoring Surgery Market Size, Share & Trends Analysis Report By Type (Oral Appliances/Mouthpieces, Position Control Devices), By Region (APAC, EU, North America), And Segment Forecasts, 2022 - 2030

Report Overview

全球鼾声设备和打鼾奔腾者y market size was valued at USD 1.42 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% over the forecast period. Increasing incidence of obesity, the launch of technologically advanced products, strategic activities by key market players, and easy availability of products through online and offline channels are major factors contributing to the growth of this market. The COVID-19 pandemic had a slight negative impact on the market. This is because, while many studies concluded that patients with obstructive sleep apnea are vulnerable to adverse post-infection outcomes, such as obesity, hypertension, and idiopathic pulmonary fibrosis, which resulted in a higher number of people being aware and opting for treatment.

However, on the other side, the pandemic led to a fall in sales of anti-snoring devices. The fall in sales can be attributed to a reduced number of elective surgeries being carried out. Moreover, severe disruption in the supply chain due to the lockdowns and restrictions, which focused on only necessary movements being carried out. The pandemic also resulted in fewer hospital visits by the patients. All of this led to a slightly negative impact on the market. However, the market began to recover in 2021 with the opening up of economies and governments coming up with better initiatives to control the spread of the virus as well as its consequences.

Moreover, the launch and regulatory approvals of new products in the last 2 years have further added to the recovery and have helped the market grow significantly. Moreover, increasing technological advancement is leading to a drastic shift and leading a larger number of customers moving towardE-commerce. The availability of a wide number of devices on the e-commerce sites will further support the growth of the market over the forecast period. The rise in the incidence of obesity has become one of the major concerns, globally. For instance, according to the CDC, the U.S. obesity prevalence between the years 2017 and 2020 was 41.9%.

它也严重obesi的患病率ty increased from 4.7% between 1999-2000 to 9.2% through 2017-2020. Factors, such as a sedentary lifestyle, increasing consumption of alcohol and smoking, and consumption of unhealthy & processed foods are leading to a rise in the number of individuals with obesity problems. Obesity-related problems include stroke, type 2 diabetes, heart disease, and certain types of cancers, which are among the leading cause of premature preventable death. In addition, people suffering from obesity may also suffer from snoring issues and sleep apnea.

Type Insights

Based on type, the market is segmented into oral appliances/mouthpieces, nasal devices, position control devices, chin straps, tongue stabilizing devices, and EPAP therapy devices. The oral appliances/mouthpieces segment dominated the global market with a revenue share of 29.83% in 2021. Factors, such as growing adoption of and awareness about oral appliances/mouthpieces among dentists and patients and the launch of technologically advanced products. Oral appliances/mouthpieces are also recommended as the first line of treatment, which has resulted in the higher adoption rate of these devices compared to other anti-snoring devices.

The position-control devices segment is estimated to register the fastest CAGR from 2022 to 2030. The PAP therapy devices segment was the second-leading type segment, in terms of revenue, in 2021. One of the main factors driving the growth of this segment includes the launch of new products and the manufacturers’ efforts to increase their sales by entering into a distribution agreement with strong regional distributors. In addition, the EPAP therapy devices have shown tremendous potential in treating patients with snoring issues and obstructive sleep apnea, which represents a great growth opportunity for this segment over the forecast period.

Regional Insights

North America dominated the global market in 2021 and accounted for the largest share of more than 37.5% of the global revenue. This can be attributed to a large number of individuals experiencing snoring in the U.S. For instance, an estimated 45% of adults snore occasionally, while 25% snore regularly, according to an article published by John Hopkins University in 2022. Another research article by Sleep Foundation states that an estimated 57% of men and 40% of women in the U.S. are affected by snoring issues. It also stated that even an estimated 27% of children are affected. A major factor leading to a rise in the number of individuals being affected with snoring issues in the region is growing obesity.

肥胖是一个大问题,特别是在美国, caused mainly due to the growing adoption of a sedentary lifestyle and an increase in the consumption of processed foods. Moreover, the presence of market players in this region and the availability of products on e-commerce sites as well as in retail stores will boost the market penetration and product reach. Asia Pacific is anticipated to register the fastest CAGR from 2022 to 2030. The region represents high growth due to the presence of a large pool of untreated individuals with snoring issues and the rising awareness regarding this condition. Growing disposable income levels are also expected to boost the product demand in this region.

Key Companies & Market Share Insights

Key players manufacturing anti-snoring devices are focusing on expanding their reach in the market through the introduction of new products. For instance, in April 2020, Apnea Sciences introduced New SnoreRx Plus. In addition, many small players in the market are also focusing on getting regulatory approvals, which is also expected to accelerate the market growth. For instance, in February 2021, Signifier Medical Technologies, LLC., received an FDA approval for the marketing of a novel device to reduce snoring and mild obstructive sleep apnea in patients aged 18 years and older. The following are some of the major players operating in the global anti-snoring devices and snoring surgery market are:

• Apnea Sciences Corp.

• SomnoMed Ltd.

• Airway Management, Inc.

• ResMed Inc.

• Fisher & Paykel Healthcare Corp. Ltd.

• Koninklijke Philips NV

• Sleep Well Enjoy Life, Ltd.

• Tomed Dr. Toussaint GmbH

• MEDiTAS Ltd.

Anti-snoring Devices And Snoring Surgery Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 1.52 billion
Revenue forecast in 2030	USD 2.65 billion
Growth rate	CAGR of 7.2% from 2022 to 2030
Base year for estimation	2021
Historical data	2017 - 2021
Forecast period	2022 - 2030
Quantitative units	Revenue in USD million/billion and CAGR from 2022 to 2030
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	Type, region
Regional scope	北美;欧洲;亚太地区;拉丁美洲; MEA
Country scope	U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; China; Japan; India; Australia; South Korea; Singapore; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE
Key companies profiled	Apnea Sciences Corp.; SomnoMed Ltd.; Airway Management, Inc.; ResMed Inc.; Fisher & Paykel Healthcare Corp. Ltd.; Koninklijke Philips NV; Sleep Well Enjoy Life, Ltd.; Tomed Dr. Toussaint GmbH; MEDiTAS Ltd.
Customization scope	Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global anti-snoring devices and snoring surgery market report based on type and region:

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Oral Appliances/Mouthpieces

  • Nasal Devices

  • Position Control Devices

  • Chin Straps

  • Tongue Stabilizing Devices

  • EPAP Therapy Devices

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Singapore

  • 拉丁美洲

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE